EA200200125A1 - Способ получения амлодипина бензолсульфоната - Google Patents

Способ получения амлодипина бензолсульфоната

Info

Publication number
EA200200125A1
EA200200125A1 EA200200125A EA200200125A EA200200125A1 EA 200200125 A1 EA200200125 A1 EA 200200125A1 EA 200200125 A EA200200125 A EA 200200125A EA 200200125 A EA200200125 A EA 200200125A EA 200200125 A1 EA200200125 A1 EA 200200125A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzenesulphonate
amlodypine
obtaining
methyl
formula
Prior art date
Application number
EA200200125A
Other languages
English (en)
Other versions
EA004208B1 (ru
Inventor
Янош Фишер
Каталин Сёке
Ласло Добаи
Шандор Левай
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of EA200200125A1 publication Critical patent/EA200200125A1/ru
Publication of EA004208B1 publication Critical patent/EA004208B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)

Abstract

Изобретение касается способа получения амлодипина бензолсульфоната формулы I с помощью реакции между бензолсульфоновой кислотой и производными 2-[/2-N-(2-карбоксибензоил)аминоэтокси/метил]-4-(2-хлорофенил)-3-этоксикарбонил-5-метоксикарбонил-6-метил-1,4-дигидропиридина общей формулы II, где Х означает водород, щелочной или щелочно-земельный металл либо четвертичный аммоний.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200125A 1999-07-05 1999-07-05 Способ получения амлодипина бензолсульфоната EA004208B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1999/000050 WO2001002360A1 (en) 1999-07-05 1999-07-05 Process for preparing amlodipine benzenesulphonate

Publications (2)

Publication Number Publication Date
EA200200125A1 true EA200200125A1 (ru) 2002-06-27
EA004208B1 EA004208B1 (ru) 2004-02-26

Family

ID=10991279

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200125A EA004208B1 (ru) 1999-07-05 1999-07-05 Способ получения амлодипина бензолсульфоната

Country Status (24)

Country Link
US (1) US6596874B1 (ru)
EP (1) EP1196383B1 (ru)
JP (1) JP3764386B2 (ru)
KR (1) KR100585442B1 (ru)
CN (1) CN1141297C (ru)
AT (1) ATE283841T1 (ru)
AU (1) AU777565B2 (ru)
BG (1) BG65657B1 (ru)
CA (1) CA2376540C (ru)
CZ (1) CZ300509B6 (ru)
DE (1) DE69922417T2 (ru)
DK (1) DK1196383T3 (ru)
EA (1) EA004208B1 (ru)
EE (1) EE05398B1 (ru)
ES (1) ES2234272T3 (ru)
HK (1) HK1044151B (ru)
MX (1) MXPA01013407A (ru)
NO (1) NO321714B1 (ru)
NZ (1) NZ517013A (ru)
PL (1) PL194193B1 (ru)
PT (1) PT1196383E (ru)
SK (1) SK285611B6 (ru)
UA (1) UA72768C2 (ru)
WO (1) WO2001002360A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354806B1 (ko) * 2000-06-21 2002-10-05 한국유나이티드제약 주식회사 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
ATE454890T1 (de) 2001-07-06 2010-01-15 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
JP2008013489A (ja) * 2006-07-06 2008-01-24 Ohara Yakuhin Kogyo Kk ベシル酸アムロジピン含有錠剤
EP1975167A1 (en) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetone solvate of phthaloyl amlodipine
CN101812014B (zh) * 2010-04-28 2011-08-24 王明 一种苯磺酸氨氯地平化合物及其制法
CN102993083A (zh) * 2012-12-21 2013-03-27 王学军 一种苯磺酸氨氯地平的制备方法
CN104262237A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 氨氯地平自由碱的合成方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
DE19738943B4 (de) 1997-09-05 2008-01-03 Siemens Ag Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls

Also Published As

Publication number Publication date
WO2001002360A1 (en) 2001-01-11
NO20020029L (no) 2002-03-05
UA72768C2 (en) 2005-04-15
EE05398B1 (et) 2011-04-15
MXPA01013407A (es) 2003-09-04
DE69922417T2 (de) 2005-12-01
NO321714B1 (no) 2006-06-26
EP1196383A1 (en) 2002-04-17
SK22002A3 (en) 2002-05-09
ATE283841T1 (de) 2004-12-15
BG65657B1 (bg) 2009-05-29
BG106164A (en) 2002-07-31
HK1044151B (zh) 2004-09-10
DE69922417D1 (de) 2005-01-05
AU777565B2 (en) 2004-10-21
SK285611B6 (sk) 2007-04-05
NO20020029D0 (no) 2002-01-04
EE200100686A (et) 2003-04-15
CN1352634A (zh) 2002-06-05
CA2376540A1 (en) 2001-01-11
CZ20014690A3 (cs) 2002-04-17
PL352493A1 (en) 2003-08-25
ES2234272T3 (es) 2005-06-16
HK1044151A1 (en) 2002-10-11
JP3764386B2 (ja) 2006-04-05
NZ517013A (en) 2003-08-29
DK1196383T3 (da) 2005-02-21
PT1196383E (pt) 2005-03-31
US6596874B1 (en) 2003-07-22
CA2376540C (en) 2007-03-13
KR100585442B1 (ko) 2006-06-02
PL194193B1 (pl) 2007-05-31
KR20020022760A (ko) 2002-03-27
AU4923799A (en) 2001-01-22
EA004208B1 (ru) 2004-02-26
EP1196383B1 (en) 2004-12-01
CZ300509B6 (cs) 2009-06-03
JP2003503477A (ja) 2003-01-28
CN1141297C (zh) 2004-03-10

Similar Documents

Publication Publication Date Title
EA200200125A1 (ru) Способ получения амлодипина бензолсульфоната
ATE292116T1 (de) Verfahren zur herstellung von donepezilderivaten
RS50287B (sr) Postupak za pripremanje citaloprama
DK1255747T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-on
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
IS6435A (is) Aðferð til framleiðslu á sítalóprami
GB0018691D0 (en) Process
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
EA200200939A1 (ru) Способ получения циталопрама
AP9901698A0 (en) Novel process.
EA200100040A1 (ru) Химический синтез морфолиновых производных
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
PT1255745E (pt) Sintese de derivados de agua soluvel 9-dihidro-paclitaxelo de 9-dihidro-13-acetilobacatina iii
FR2803846B1 (fr) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, son procede de preparation et son utilisation
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
ATE479661T1 (de) Verfahren zur herstellung von pestiziden verbindungen
TR200003360T2 (tr) Farmasotik norbenzomorfan türevleri imalatı için iyileştirilmiş yöntem
DE60127979D1 (de) Verfahren zur herstellung von 3,5-bisalkylphenolen
HUP0002772A2 (hu) Eljárás királis 3,4-dehidroprolinok előállítására
DK1242390T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner

Legal Events

Date Code Title Description
MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM RU